JLL's Michel Lagarde appointed president of Patheon
Patheon, a Canadian-born drug development and manufacturing services provider, has named Michel Lagarde its president. Lagarde joins the company from JLL Partners, the U.S. private equity that helped take Patheon private for US$1.4 billion in March 2014. The deal saw the business amalgamated with a subsidiary of DPx, formed by JLL and Royal DSM. Patheon, which continues to have offices in Canada, is now based in Durham, North Carolina.
3 June 2016•3 mins read
